These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16260969)

  • 21. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-receptor blockade, physical activity, and metabolism.
    Lohmann FW; Loesment WA; Kaehler H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S45-52. PubMed ID: 11527136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate deflection related to lactate performance curve and plasma catecholamine response during incremental cycle ergometer exercise.
    Pokan R; Hofmann P; Lehmann M; Leitner H; Eber B; Gasser R; Schwaberger G; Schmid P; Keul J; Klein W
    Eur J Appl Physiol Occup Physiol; 1995; 70(2):175-9. PubMed ID: 7768241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of beta-adrenoceptor selectivity of a new beta-adrenoceptor antagonist, bisoprolol, in man.
    Tattersfield AE; Cragg DJ; Bacon RJ
    Br J Clin Pharmacol; 1984 Sep; 18(3):343-7. PubMed ID: 6148959
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of the application of the heart rate performance curve in sports.
    Hofmann P; Pokan R
    Int J Sports Physiol Perform; 2010 Dec; 5(4):437-47. PubMed ID: 21266729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Greater glycogen utilization during 1- than 2-adrenergic receptor stimulation in the isolated perfused rat heart.
    McConville P; Lakatta EG; Spencer RG
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1828-35. PubMed ID: 17911346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart rate threshold related to lactate turn point and steady-state exercise on a cycle ergometer.
    Hofmann P; Bunc V; Leitner H; Pokan R; Gaisl G
    Eur J Appl Physiol Occup Physiol; 1994; 69(2):132-9. PubMed ID: 7805667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of selective beta 2-adrenoceptor blockade on serum potassium and exercise performance in normal men.
    Gullestad L; Birkeland K; Nordby G; Larsen S; Kjekshus J
    Br J Clin Pharmacol; 1991 Aug; 32(2):201-7. PubMed ID: 1681847
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of beta-adrenoceptor agonists and antagonists on heart-rate variability in normal subjects assessed using summary statistics and nonlinear procedures.
    Silke B; Guy S; Riddell JG
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):817-23. PubMed ID: 9436823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The asthmatic athlete: metabolic and ventilatory responses to exercise with and without pre-exercise medication.
    Ienna TM; McKenzie DC
    Int J Sports Med; 1997 Feb; 18(2):142-8. PubMed ID: 9081272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
    Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β
    Cook RF; Bussey CT; Mellor KM; Cragg PA; Lamberts RR
    Exp Physiol; 2017 Aug; 102(8):911-923. PubMed ID: 28543947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.
    Willette RN; Aiyar N; Yue TL; Mitchell MP; Disa J; Storer BL; Naselsky DP; Stadel JM; Ohlstein EH; Ruffolo RR
    J Pharmacol Exp Ther; 1999 Apr; 289(1):48-53. PubMed ID: 10086986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of experimental autoimmune cardiomyopathy in rabbits by receptor blockers.
    Matsui S; Fu ML
    Autoimmunity; 2001; 34(3):217-20. PubMed ID: 11908781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A metabolic assessment of the beta 1 selectivity of bisoprolol.
    Haffner CA; Horton RC; Lewis HM; Hughes B; Kendall MJ
    J Hum Hypertens; 1992 Oct; 6(5):397-400. PubMed ID: 1361206
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of normoxic endurance exercise on erythropoietin (EPO) production and the impact of selective β
    Azadan RJ; Agha NH; Kunz HE; Baker FL; Mylabathula PL; Ledoux TA; O'Connor DP; Pedlar CR; Simpson RJ
    Eur J Appl Physiol; 2021 May; 121(5):1499-1511. PubMed ID: 33646423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in platelet size and spleen volume in response to selective and non-selective beta-adrenoceptor blockade in hypertensive patients.
    Bakovic D; Pivac N; Eterovic D; Palada I; Valic Z; Paukovic-Sekulic B; Dujic Z
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):441-6. PubMed ID: 19702597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
    Baker JG
    Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisoprolol attenuates noradrenaline- and phenylephrine-evoked venoconstriction in man in vivo.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1997 Jul; 44(1):61-8. PubMed ID: 9241098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.